Related Experiment Video
Updated: Mar 19, 2026
11:39
Identifying Cell Surface Markers of Primary Neural Stem and Progenitor Cells by Metabolic Labeling of Sialoglycan
Published on: September 7, 2019
5.8K
Glycosphingolipids of human embryonic stem cells
Michael E Breimer1, Karin Säljö1, Angela Barone2
1Institute of Clinical Sciences, Department of Surgery, Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden.
Glycoconjugate Journal
|June 22, 2016
Summary
Human stem cell research shows potential for disease treatment. Cell surface carbohydrate antigens, like SSEA-3 and SSEA-4, are key markers for pluripotent stem cells and their differentiation.
Area of Science:
- Biochemistry
- Stem Cell Biology
- Immunology
Background:
- Human stem cell technology holds promise for treating diseases, but requires solving scientific challenges.
- Cell surface carbohydrate antigens play crucial roles in stem cell differentiation and immune reactivity.
- These carbohydrate epitopes are ideal for characterizing human pluripotent stem cells due to their surface localization.
Purpose of the Study:
- To review recent biochemical studies expanding knowledge of glycosphingolipids in human embryonic stem cells.
- To discuss the distribution of human pluripotent stem cell glycosphingolipids in human tissues.
- To explore glycosphingolipid changes during human stem cell differentiation.
Main Methods:
- Focus on biochemical studies of glycosphingolipids in human embryonic stem cells.
- Analysis of cell surface carbohydrate antigens, including globo-series glycosphingolipids SSEA-3 and SSEA-4.
- Review of existing immunological assays and recent biochemical data.
Main Results:
- Recent biochemical studies have significantly advanced the understanding of human embryonic stem cell glycosphingolipids.
- Glycosphingolipid expression on human pluripotent stem cells is crucial for their characterization.
- SSEA-3 and SSEA-4 are identified as key markers for human pluripotent stem cells.
Conclusions:
- Biochemical studies are enhancing our understanding of glycosphingolipids in human stem cells.
- Further research into glycosphingolipid distribution and changes during differentiation is warranted.
- Characterizing cell surface glycosphingolipids is vital for the clinical application of stem cell technology.
Related Concept Videos
00:57Embryonic Stem Cells
5.9K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.9K
00:58Embryonic Stem Cells
33.2K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.2K
01:24Oligosaccharide Assembly
3.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.8K